Article ; Online: The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma.
2021 Volume 12, Issue 2, Page(s) 11124–11135
Abstract: to explore the value of transcatheter arterial chemoembolization (TACE) combined with targeted nanoparticle delivery system for sorafenib (SFB) to treat hepatocellular carcinoma (HCC) with microvascular invasion. 42 HCC patients with microvascular ... ...
Abstract | to explore the value of transcatheter arterial chemoembolization (TACE) combined with targeted nanoparticle delivery system for sorafenib (SFB) to treat hepatocellular carcinoma (HCC) with microvascular invasion. 42 HCC patients with microvascular invasion after liver cancer surgery were selected from our hospital from December 2020 and February 2021. Patients were divided into experimental group and control group based on their willingness. Patients in experimental group (18 cases) were treated with combination therapy of TACE and Ab-SFB-NP system; while patients in control group (24 cases) took TACE and non-nano drug delivery system. There was no obvious difference in liver function and blood test results between two groups of patients before treatment and one month after treatment ( |
---|---|
MeSH term(s) | Carcinoma, Hepatocellular/blood ; Carcinoma, Hepatocellular/blood supply ; Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/physiopathology ; Catheterization ; Chemoembolization, Therapeutic/adverse effects ; Female ; Humans ; Liver/pathology ; Liver/physiopathology ; Liver Neoplasms/blood ; Liver Neoplasms/blood supply ; Liver Neoplasms/drug therapy ; Liver Neoplasms/physiopathology ; Male ; Microvessels/pathology ; Middle Aged ; Nanoparticles/chemistry ; Neoplasm Invasiveness ; Sorafenib/adverse effects ; Sorafenib/therapeutic use |
Chemical Substances | Sorafenib (9ZOQ3TZI87) |
Language | English |
Publishing date | 2021-12-20 |
Publishing country | United States |
Document type | Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2737830-5 |
ISSN | 2165-5987 ; 2165-5979 |
ISSN (online) | 2165-5987 |
ISSN | 2165-5979 |
DOI | 10.1080/21655979.2021.2001239 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.